It's the same market but different baseline products, so it's like comparing apples to oranges. MXC makes skin care products while MMJ looks to be focusing on Pharma edible capsules, with both involved in cultivation and distribution.
While they share the same industry space it seems hard to compare without actually seeing net profits. MXC holds a 1.3mil eu skin care deal while report says "Satipharm’s flagship product, Gelpell-CBD Microgel Capsules, now available for sale throughout all pharmaceutical outlets in Germany", but until you get annual report with profit share it's hard to determine the value of a sales figure which would be a purely hypothetical guess at best.
MMJ Price at posting:
75.0¢ Sentiment: Hold Disclosure: Held
